CG Oncology Inc. Common s...

NASDAQ: CGON · Real-Time Price · USD
25.71
-0.25 (-0.96%)
At close: Aug 15, 2025, 3:59 PM
25.70
-0.04%
After-hours: Aug 15, 2025, 04:54 PM EDT

CG Oncology Common stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
257.07M 8.27M 88.14M 53.61M
Short-Term Investments
484.93M 179.41M 55.34M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
94K 4.69M 33K 85K
Receivables
781K 92K 303K 2K
Inventory
n/a n/a n/a n/a
Other Current Assets
11.43M 6.36M 3.42M 4.8M
Total Current Assets
754.21M 194.12M 147.21M 58.41M
Property-Plant & Equipment
493K 491K 506K 200K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
587K 5.18M 539K 285K
Total Assets
754.8M 199.3M 147.75M 58.69M
Account Payables
6.52M 3.24M 985K 1M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
186K 569K 8.97M 2.94M
Other Current Liabilities
6.04M 3.72M 173K 68K
Total Current Liabilities
21.37M 14.25M 15.43M 5.97M
Long-Term Debt
n/a 13K 6.53M 12.06M
Other Long-Term Liabilities
n/a 13K 352K 351K
Total Long-Term Liabilities
52K 257K 7.14M 12.46M
Total Liabilities
21.42M 14.51M 22.57M 18.44M
Total Debt
238K 461K 15.94M 15.13M
Common Stock
8K n/a 4K 3K
Retained Earnings
-217.98M -129.94M -81.33M -45.89M
Comprehensive Income
n/a n/a n/a -3K
Shareholders Equity
733.38M 184.79M 125.18M 40.25M
Total Investments
484.93M 179.41M 55.34M n/a